-
-
-
-
-
-
-
PDS Biotechnology presents immunotherapy data at cancer conference
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on PDS Biotechnology Corp (PDSB)
-
-
-
-
-
-
-
PDS Biotechnology (PDSB) Announces $22M Offering at $1.50/sh
-
-
-
-
-
-
-
PDS Biotechnology (PDSB) Tops Q2 EPS by 10c
-
-
-
408,934 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

